ROQ — Roquefort Therapeutics Share News
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
- £2.87m
- £2.87m
- £0.00m
REG - Roquefort Theraptcs. - Director/PDMR Shareholding
AnnouncementREG - Roquefort Theraptcs. - RNA Medicine Shows In Vitro Anti-Cancer Efficacy
AnnouncementREG - Roquefort Theraptcs. - Antibody Program Results & Orphan Drug Indication
AnnouncementREG - Roquefort Theraptcs. - Anti-Cancer MDK mRNA - Positive in vitro Results
AnnouncementREG - Roquefort Theraptcs. - Restoration of Trading
AnnouncementREG - Roquefort Theraptcs. - Notice of Annual General Meeting
AnnouncementREG - Roquefort Theraptcs. - Annual Report & Financial Statements - 31 Dec 2022
AnnouncementREG - Roquefort Theraptcs. - Suspension of Trading Pending 2022 Annual Report
AnnouncementREG - Official List Roquefort Theraptcs. - Suspension - Roquefort Therapeutics plc
AnnouncementREG - Roquefort Theraptcs. - Confirmation of No Exposure to Silicon Valley Bank
AnnouncementREG - Roquefort Theraptcs. - Creation of New Novel Family of mRNA Therapeutics
AnnouncementREG - Hot Rocks Inv PLC - Interim Results to 30 September 2022
AnnouncementREG - Roquefort Theraptcs. - Formation of Scientific Advisory Board
AnnouncementRCS - Roquefort Theraptcs. - Company Presentation
AnnouncementRCS - Roquefort Theraptcs. - Investor Presentation
AnnouncementREG - Roquefort Theraptcs. - Randox Licence and Royalty Agreement
AnnouncementREG - Roquefort Theraptcs. - MDK Oncology Antibodies Demonstrate In-Vivo Safety
AnnouncementREG - Roquefort Theraptcs. - Holding(s) in Company
AnnouncementREG - Roquefort Theraptcs. - Appointment of Auditor
Announcement